Your views
Your feedback is vital to us as we continue to increase the quality of our services.
You are here:
Date: 26 December 2024
Time: 09:10
UHB selected to join Oxford Vaccine Group’s COVID-19 vaccine trial
Story posted/last updated: 22 May 2020
University Hospitals Birmingham NHS Foundation Trust (UHB) has today been selected as one of 18 Trusts recruiting to the Oxford Vaccine Group’s COVID-19 vaccine trial.
The trial aims to test the effectiveness of a vaccine in protecting people from COVID-19.
Recruitment of staff who may wish to volunteer to participate in the trial will start today. The trial will aim to assess how the vaccine works in a large number of people in preventing COVID-19 infection.
Staff volunteering to take part will be assessed and, if recruited, will either receive the trial vaccine or a “control” licensed vaccine to act as a comparison.
Staff taking part will not know which vaccine they have received until the trial ends, with screening and vaccinations due to take place across UHB sites in May and June.
More information on the trial, as well as a blog post explaining more about the vaccine trial is available in the "Links" section below.
University Hospitals Birmingham NHS Foundation Trust is not responsible for the contents or the reliability of external websites and does not necessarily endorse the views expressed within them. Listing should not be taken as endorsement of any kind. We cannot guarantee that links to other websites will work all of the time, and we have no control over the availability of external web pages.
Getting here
Information about travelling to, staying at and getting around the hospital.
Jobs at UHB
A great place to work. Learn why.
news@UHB
RSS feed
Subscribe to our news feed
